R I Baker|A Manoharan - JoVE Visualize

Showing results (111-120 of 122) with videos related to

Pageof 13

Sort By:

Journal of Thrombosis and Haemostasis : JTH|July 23, 2003

Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic strokeV J Cole, J M Staton, J W Eikelboom, et al.

Acta Tropica|December 1, 1995

Frequency distribution of Wuchereria bancrofti infection in the vector host in relation to human host: evidence for density dependenceP K Das, S Subramanian, A Manoharan, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2010

Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre studyS Dunkley, R I Baker, M Pidcock, et al.

Journal of Thrombosis and Haemostasis : JTH|October 1, 2018

Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopeniaB D Wines, C W Tan, E Duncan, et al.

Australian and New Zealand Journal of Medicine|February 1, 1986

A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.

Journal of Thrombosis and Haemostasis : JTH|May 20, 2008

Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpuraE E Gardiner, M Al-Tamimi, F-T Mu, et al.

Thrombosis and Haemostasis|January 31, 2002

Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome studyB H Chong, A S Gallus, J F Cade, et al.

Bone|November 15, 2008

Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic ricketsEmily G Farrow, Siobhan I Davis, Leanne M Ward, et al.

Cancer Treatment Reports|December 1, 1987

Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.

Australian and New Zealand Journal of Medicine|March 4, 1998

Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New ZealandJ V Lloyd, A M Street, E Berry, et al.

Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:

Pageof 13

Journal of Thrombosis and Haemostasis : JTH|July 23, 2003

Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic strokeV J Cole, J M Staton, J W Eikelboom, et al.

Acta Tropica|December 1, 1995

Frequency distribution of Wuchereria bancrofti infection in the vector host in relation to human host: evidence for density dependenceP K Das, S Subramanian, A Manoharan, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2010

Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre studyS Dunkley, R I Baker, M Pidcock, et al.

Journal of Thrombosis and Haemostasis : JTH|October 1, 2018

Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopeniaB D Wines, C W Tan, E Duncan, et al.

Australian and New Zealand Journal of Medicine|February 1, 1986

A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemiaJ F Bishop, D E Joshua, R M Lowenthal, et al.

Journal of Thrombosis and Haemostasis : JTH|May 20, 2008

Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpuraE E Gardiner, M Al-Tamimi, F-T Mu, et al.

Thrombosis and Haemostasis|January 31, 2002

Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome studyB H Chong, A S Gallus, J F Cade, et al.

Bone|November 15, 2008

Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic ricketsEmily G Farrow, Siobhan I Davis, Leanne M Ward, et al.

Cancer Treatment Reports|December 1, 1987

Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.

Australian and New Zealand Journal of Medicine|March 4, 1998

Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New ZealandJ V Lloyd, A M Street, E Berry, et al.

Pageof 13